208 related articles for article (PubMed ID: 22450679)
1. The feasibility of enzyme targeted activation for amino acid/dipeptide monoester prodrugs of floxuridine; cathepsin D as a potential targeted enzyme.
Tsume Y; Amidon GL
Molecules; 2012 Mar; 17(4):3672-89. PubMed ID: 22450679
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.
Tsume Y; Hilfinger JM; Amidon GL
Mol Pharm; 2008; 5(5):717-27. PubMed ID: 18652477
[TBL] [Abstract][Full Text] [Related]
3. Selection of suitable prodrug candidates for in vivo studies via in vitro studies; the correlation of prodrug stability in between cell culture homogenates and human tissue homogenates.
Tsume Y; Amidon GL
J Pharm Pharm Sci; 2012; 15(3):433-46. PubMed ID: 22974791
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery to PEPT1-overexpressing cells: acidic, basic, and secondary floxuridine amino acid ester prodrugs.
Landowski CP; Vig BS; Song X; Amidon GL
Mol Cancer Ther; 2005 Apr; 4(4):659-67. PubMed ID: 15827340
[TBL] [Abstract][Full Text] [Related]
5. Enhanced absorption and growth inhibition with amino acid monoester prodrugs of floxuridine by targeting hPEPT1 transporters.
Tsume Y; Vig BS; Sun J; Landowski CP; Hilfinger JM; Ramachandran C; Amidon GL
Molecules; 2008 Jun; 13(7):1441-54. PubMed ID: 18719516
[TBL] [Abstract][Full Text] [Related]
6. Potential of amino acid/dipeptide monoester prodrugs of floxuridine in facilitating enhanced delivery of active drug to interior sites of tumors: a two-tier monolayer in vitro study.
Tsume Y; Hilfinger JM; Amidon GL
Pharm Res; 2011 Oct; 28(10):2575-88. PubMed ID: 21671137
[TBL] [Abstract][Full Text] [Related]
7. The dipeptide monoester prodrugs of floxuridine and gemcitabine-feasibility of orally administrable nucleoside analogs.
Tsume Y; Borras Bermejo B; Amidon GL
Pharmaceuticals (Basel); 2014 Jan; 7(2):169-91. PubMed ID: 24473270
[TBL] [Abstract][Full Text] [Related]
8. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
Tsume Y; Drelich AJ; Smith DE; Amidon GL
Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
[TBL] [Abstract][Full Text] [Related]
9. Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis.
Vig BS; Lorenzi PJ; Mittal S; Landowski CP; Shin HC; Mosberg HI; Hilfinger JM; Amidon GL
Pharm Res; 2003 Sep; 20(9):1381-8. PubMed ID: 14567631
[TBL] [Abstract][Full Text] [Related]
10. The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stability.
Tsume Y; Incecayir T; Song X; Hilfinger JM; Amidon GL
Eur J Pharm Biopharm; 2014 Apr; 86(3):514-23. PubMed ID: 24361461
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside ester prodrug substrate specificity of liver carboxylesterase.
Landowski CP; Lorenzi PL; Song X; Amidon GL
J Pharmacol Exp Ther; 2006 Feb; 316(2):572-80. PubMed ID: 16223870
[TBL] [Abstract][Full Text] [Related]
12. Bifunctional and Unusual Amino Acid β- or γ-Ester Prodrugs of Nucleoside Analogues for Improved Affinity to ATB
Sun Y; Ke Y; Li C; Wang J; Tu L; Hu L; Jin Y; Chen H; Gong J; Yu Z
J Med Chem; 2020 Oct; 63(19):10816-10828. PubMed ID: 32882127
[TBL] [Abstract][Full Text] [Related]
13. Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism.
Landowski CP; Song X; Lorenzi PL; Hilfinger JM; Amidon GL
Pharm Res; 2005 Sep; 22(9):1510-8. PubMed ID: 16132363
[TBL] [Abstract][Full Text] [Related]
14. Interaction of intestinal nucleoside transporter hCNT2 with amino acid ester prodrugs of floxuridine and 2-bromo-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
Shin HC; Kim JS; Vig BS; Song X; Drach JC; Amidon GL
Biol Pharm Bull; 2006 Feb; 29(2):247-52. PubMed ID: 16462026
[TBL] [Abstract][Full Text] [Related]
15. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
16. A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.
Kim I; Song X; Vig BS; Mittal S; Shin HC; Lorenzi PJ; Amidon GL
Mol Pharm; 2004; 1(2):117-27. PubMed ID: 15832508
[TBL] [Abstract][Full Text] [Related]
17. Improved Protease-Targeting and Biopharmaceutical Properties of Novel Prodrugs of Ganciclovir.
Sun K; Xu H; Hilfinger JL; Lee KD; Provoda CJ; Sabit H; Amidon GL
Mol Pharm; 2018 Feb; 15(2):410-419. PubMed ID: 29251944
[TBL] [Abstract][Full Text] [Related]
18. Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
Janssen S; Jakobsen CM; Rosen DM; Ricklis RM; Reineke U; Christensen SB; Lilja H; Denmeade SR
Mol Cancer Ther; 2004 Nov; 3(11):1439-50. PubMed ID: 15542783
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic activation of indolequinone-substituted 5-fluorodeoxyuridine prodrugs in hypoxic cells.
Jiho Y; Kurihara R; Kawai K; Yamada H; Uto Y; Tanabe K
Bioorg Med Chem Lett; 2019 Jun; 29(11):1304-1307. PubMed ID: 30975626
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of floxuridine loaded polycation and its antitumor activity].
Zhao DJ; Lu X; Jiang QY; Chen D; Zhou J; Yu H; Wang QQ; Tang GP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 38(1):53-8. PubMed ID: 19253429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
